32
Participants
Start Date
Not specified
Study Completion Date
June 30, 2002
Zidovudine
Didanosine
Univ of Pittsburgh, Pittsburgh
Univ of Maryland at Baltimore, Baltimore
Duke Univ Med Ctr, Durham
Univ of Illinois, Chicago
Kaiser Permanente Med Ctr, San Francisco
Mount Zion Med Ctr / UCSF, San Francisco
Palo Alto Veterans Affairs Health Care System, Palo Alto
SUNY / Health Sciences Ctr at Stony Brook, Stony Brook
Collaborators (2)
Bristol-Myers Squibb
INDUSTRY
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH